Tsukuba, Japan

Mineo Kunihara


Average Co-Inventor Count = 8.6

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Tsukuba, JP (1995 - 1997)
  • Ibaraki, JP (1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mineo Kunihara: Innovator in Pharmaceutical Chemistry

Introduction

Mineo Kunihara is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tropolone derivatives. With a total of 3 patents to his name, Kunihara's inventions focus on the prevention and treatment of ischemic diseases.

Latest Patents

Kunihara's latest patents include novel tropolone derivatives that are designed for pharmaceutical compositions. These compounds are characterized by a specific formula where R10 is a substituted or unsubstituted piperazinyl or benzothiazolidinyl group. The inventions aim to provide effective solutions for ischemic diseases, including cerebrovascular and cardiovascular diseases.

Career Highlights

Throughout his career, Mineo Kunihara has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with The Upjohn Company and Pharmacia & Upjohn Company. His work in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Kunihara has collaborated with esteemed colleagues in his field, including Noriie Itoh and Hiroshi Kushida. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Mineo Kunihara stands out as a significant figure in pharmaceutical innovation, with a focus on tropolone derivatives that address critical health issues. His contributions continue to impact the field positively, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…